Stalevo
Stalevo

0.95
A generic alternative indicated for Neurology. It replaces dopamine levels in the brain to facilitate motor control and reduce tremors associated with neurological movement.


Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Levodopa, Carbidopa, Entacapone
Product Origin
Generic Alternative
Reference Manufacturer
Novartis (Orion)
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Neurology, Parkinson's Care
Product Category
Antiparkinsonian Combination
Pharmacological Class
Dopamine precursor and COMT inhibitor
Manufacturer Description
A triple-combination therapy developed to manage Parkinson's symptoms and designed to alleviate 'off' periods by supporting steady brain dopamine levels.
Mechanism of Action
Levodopa replaces dopamine. Carbidopa prevents peripheral breakdown. Entacapone inhibits COMT enzymes, which allows more levodopa to reach the brain and last longer.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
3–5 hours
Contraindications
Narrow-angle glaucoma, History of melanoma, Use of non-selective MAOIs, Pheochromocytoma
Severe Adverse Events
Neuroleptic Malignant Syndrome, Rhabdomyolysis, Sudden sleep attacks, Melanoma risk
Common Side Effects
Nausea, Dizziness, Urine discoloration (orange/brown)
Uncommon Side Effects
Dyskinesia (uncontrolled movements), Diarrhea, Hallucinations, Orthostatic hypotension
Drug Interactions
MAOIs, Iron supplements, Metoclopramide, Antipsychotics
Pregnancy Safety Warnings
Use only if clearly needed.
Age Restrictions
For adult use.
Storage Guidelines
Store at room temperature in a dry place.
Related Products
Sinemet, Madopar
Information for Stalevo is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories